The advent of immunotherapy for the treatment of gastrointestinal cancers has placed biomarker testing at the forefront of patient management. In this live webinar, experts will discuss the latest evidence on biomarkers and immunotherapies, provide insights on applying cutting-edge clinical trial data, as well as share best practices on advancing gastroesophageal and colorectal cancer care in federal, public, and government healthcare settings. Don’t miss this opportunity to enhance your skills in delivering personalized, evidence-based care!
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/virtual/gastroesophageal-colorectal-cancers-gi-cancers-recent-immunotherapy-evidence
- Start Date: 2025-03-25 05:00:00
- End Date: 2025-03-25 05:00:00
- Credit Details: IPCE Credits: 0.5 hours
AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - MOC Credit Details: ABIM - 0.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Aveo Pharmaceuticals - Amount: 2083.33 - Is Kind Support: False Source: Merck (Any division) - Amount: 16666.67 - Is Kind Support: False
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest